Cargando…

miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3

PURPOSE: This study aimed to investigate the effects of microRNA (miR)-22 on biological behaviors of colon cancer cells and to explore the relationship between miR-22 and NLRP3. MATERIALS AND METHODS: First, human colon cancer HCT116 cells were transfected with a miR-22 mimic, miR-22 inhibitor, cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Jinchun, Gong, Jian, Yang, Chuanjia, Xia, Zhixiu, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351629/
https://www.ncbi.nlm.nih.gov/pubmed/32753959
http://dx.doi.org/10.2147/CMAR.S255125
_version_ 1783557474850177024
author Cong, Jinchun
Gong, Jian
Yang, Chuanjia
Xia, Zhixiu
Zhang, Hong
author_facet Cong, Jinchun
Gong, Jian
Yang, Chuanjia
Xia, Zhixiu
Zhang, Hong
author_sort Cong, Jinchun
collection PubMed
description PURPOSE: This study aimed to investigate the effects of microRNA (miR)-22 on biological behaviors of colon cancer cells and to explore the relationship between miR-22 and NLRP3. MATERIALS AND METHODS: First, human colon cancer HCT116 cells were transfected with a miR-22 mimic, miR-22 inhibitor, control mimic, and control inhibitor, respectively. CCK8, colony formation, and transwell assays were performed to observe cell proliferation, migration, and invasion. Western blotting was used to analyze the expression of recombinant NLRP3 (NLR family, pyrin domain-containing protein 3) and epithelial–mesenchymal transformation (EMT)-related proteins. The target relationship between miR-22 and NLRP3 was verified by double luciferase report. Second, an NLRP3 inhibitor and NLRP3 mimic were transfected into HCT116 cells, and the biological behaviors and EMT-related proteins were again observed. Finally, a nude mouse xenograft model was constructed to verify the above results. RESULTS: In vitro, compared with the control group, administration of the miR-22 mimic significantly decreased proliferation, migration, and invasion of HCT116 cells, whereas the miR-22 inhibitor markedly increased their proliferation and invasion (p<0.05). Levels of NLRP3, interleukin-1β (IL-1β), matrix metalloproteinase-9 (MMP-9), MMP-2, N-cadherin, and vimentin were significantly reduced after miR-22 mimic transfection (p<0.05). Furthermore, silencing of NLRP3, a downstream gene of miR-22 in HCT116 cells, suppressed proliferation, migration, and invasion of HCT116 cells. However, overexpression of NLRP3 weakened the effects of the miR-22 mimic. In vivo, overexpression of miR-22 slowed the growth rate of tumors and reduced Ki-67 expression in tumor tissues compared with the model group (p<0.05). In tumor tissues, overexpression of miR-22 also decreased expression of NLRP3, IL-1β, MMP-9, MMP-2, N-cadherin, and vimentin compared with the model group (p<0.05). Overexpression of NLRP3 weakened the role of miR-22 overexpression in vivo. CONCLUSION: miR-22 suppresses cell proliferation, migration, and invasion in colorectal cancer by targeting NLRP3.
format Online
Article
Text
id pubmed-7351629
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73516292020-08-03 miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3 Cong, Jinchun Gong, Jian Yang, Chuanjia Xia, Zhixiu Zhang, Hong Cancer Manag Res Original Research PURPOSE: This study aimed to investigate the effects of microRNA (miR)-22 on biological behaviors of colon cancer cells and to explore the relationship between miR-22 and NLRP3. MATERIALS AND METHODS: First, human colon cancer HCT116 cells were transfected with a miR-22 mimic, miR-22 inhibitor, control mimic, and control inhibitor, respectively. CCK8, colony formation, and transwell assays were performed to observe cell proliferation, migration, and invasion. Western blotting was used to analyze the expression of recombinant NLRP3 (NLR family, pyrin domain-containing protein 3) and epithelial–mesenchymal transformation (EMT)-related proteins. The target relationship between miR-22 and NLRP3 was verified by double luciferase report. Second, an NLRP3 inhibitor and NLRP3 mimic were transfected into HCT116 cells, and the biological behaviors and EMT-related proteins were again observed. Finally, a nude mouse xenograft model was constructed to verify the above results. RESULTS: In vitro, compared with the control group, administration of the miR-22 mimic significantly decreased proliferation, migration, and invasion of HCT116 cells, whereas the miR-22 inhibitor markedly increased their proliferation and invasion (p<0.05). Levels of NLRP3, interleukin-1β (IL-1β), matrix metalloproteinase-9 (MMP-9), MMP-2, N-cadherin, and vimentin were significantly reduced after miR-22 mimic transfection (p<0.05). Furthermore, silencing of NLRP3, a downstream gene of miR-22 in HCT116 cells, suppressed proliferation, migration, and invasion of HCT116 cells. However, overexpression of NLRP3 weakened the effects of the miR-22 mimic. In vivo, overexpression of miR-22 slowed the growth rate of tumors and reduced Ki-67 expression in tumor tissues compared with the model group (p<0.05). In tumor tissues, overexpression of miR-22 also decreased expression of NLRP3, IL-1β, MMP-9, MMP-2, N-cadherin, and vimentin compared with the model group (p<0.05). Overexpression of NLRP3 weakened the role of miR-22 overexpression in vivo. CONCLUSION: miR-22 suppresses cell proliferation, migration, and invasion in colorectal cancer by targeting NLRP3. Dove 2020-07-06 /pmc/articles/PMC7351629/ /pubmed/32753959 http://dx.doi.org/10.2147/CMAR.S255125 Text en © 2020 Cong et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Cong, Jinchun
Gong, Jian
Yang, Chuanjia
Xia, Zhixiu
Zhang, Hong
miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
title miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
title_full miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
title_fullStr miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
title_full_unstemmed miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
title_short miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3
title_sort mir-22 suppresses tumor invasion and metastasis in colorectal cancer by targeting nlrp3
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351629/
https://www.ncbi.nlm.nih.gov/pubmed/32753959
http://dx.doi.org/10.2147/CMAR.S255125
work_keys_str_mv AT congjinchun mir22suppressestumorinvasionandmetastasisincolorectalcancerbytargetingnlrp3
AT gongjian mir22suppressestumorinvasionandmetastasisincolorectalcancerbytargetingnlrp3
AT yangchuanjia mir22suppressestumorinvasionandmetastasisincolorectalcancerbytargetingnlrp3
AT xiazhixiu mir22suppressestumorinvasionandmetastasisincolorectalcancerbytargetingnlrp3
AT zhanghong mir22suppressestumorinvasionandmetastasisincolorectalcancerbytargetingnlrp3